For episode 5, we chat with Matt Schwartz, CEO & Co-Founder of Virgo.
Listen in to  find out Matt's thoughts on Decentralized Clinical Trials and why they aren't really applied well in the realm of IBD trials.

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder.

Episodes launch weekly on Tuesdays.

To view the full episode transcript, click here.

Interested in being featured as a guest on First In Human? Please reach out to [email protected].

🎧 Stay in the Loop!

For the latest news and updates, visit our website: https://vial.com

Follow us on social media for real-time insights:

Twitter: https://twitter.com/VialTrials

LinkedIn: https://www.linkedin.com/company/vialtrials